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The two large Rep proteins, Rep78 and Rep68, from the adeno-associated virus type 2 (AAV-2) are required for AAV-2 DNA replication,
site-specific integration, and for the regulation of viral gene expression. The study of their activities is dependent on the ability to deliver
these proteins to the cells in a time and dose-dependent manner. We evaluated the ability of a protein transduction domain (PTD) derived
from the human immunodeficiency virus 1 (HIV-1) TAT protein to drive the cellular internalization of exogenously delivered PTD-fused
Rep68 proteins. This analysis unexpectedly revealed that recombinant Rep68 alone, in the absence of any PTD, could be endocytosed by the
cells. Rep68 as the chimeric TAT-Rep68 proteins were internalized through endocytosis in clathrin-coated vesicles and retained in late
endosomes/lysosomes with no detectable nuclear localization. In the presence of adenovirus, the Rep proteins could translocate into the
nucleus where they displayed a biological activity. These findings support recent reports on the mechanism of entry of TAT-fused proteins
and also revealed a new property of Rep68.
D 2005 Elsevier Inc. All rights reserved.
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Adeno-associated virus type 2 (AAV-2) is a human
parvovirus that replicates in the presence of a helper virus
such as adenovirus or herpes simplex virus-1 and -2. In the
absence of a helper virus, AAV can persist in a latent state
that can lead, at least in vitro, to the site-specific integration
of the viral genome in human chromosome 19 (Berns and
Linden, 1995). The 4.7-kb genome of AAV-2 contains two
open reading frames (ORFs), rep and cap, flanked by two
inverted terminal repeat (ITR) that constitute the cis-acting
elements required for DNA replication. The rep ORF leads
to the synthesis of four regulatory proteins, Rep78, 68, 52,
and 40 proteins. The cap ORF encodes for the three proteins
(VP1, 2, and 3) that constitute the capsid (Berns and Giraud,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.02.024
T Corresponding author. Fax: +33 240087491.
E-mail address: anna.salvetti@univ-nantes.fr (A. Salvetti).1996). The Rep proteins, and particularly Rep78 and 68,
have been shown to be required for AAV replication,
regulation AAV gene transcription, and site-specific inte-
gration (Berns and Giraud, 1996).
Because the Rep proteins are critical for many aspects of
the AAV life cycle, they have been the focus of many
studies. Generally, their activity is evaluated in cells
transiently transfected with rep-expressing plasmids. How-
ever, this method does not allow control of the amount of
protein synthetized that is critical to induce efficient
replication and site-specific integration of AAV DNA (Li
et al., 1997; Young et al., 2000).
In this study, we evaluated an alternative delivery method
based on the use of recombinant Rep proteins fused to a
protein transduction domain (PTD). Indeed, previous
studies have indicated that a limited number of small
protein domains, such as those derived from the HIV-1 TAT
protein, have the ability to penetrate cells upon their
addition in the media (for a review, see Leifert and Whitton,05) 252–263
R. Awedikian et al. / Virology 335 (2005) 252–263 2532003). Even if cellular uptake of PTDs and PTDs-fused
proteins has remained mysterious for several years, recent
studies have shown convincing evidence for the involve-
ment of endocytosis as the dominant mechanism for cellular
internalization (Leifert and Whitton, 2003).
The comparative analysis of recombinant Rep proteins
fused or not to the TAT PTD unexpectedly revealed that
Rep68 alone, in the absence of TAT, could similarly be
endocytosed by the cells. The recombinant Rep68 as the
chimeric TAT-Rep68 proteins were internalized by the cells
through endocytosis in clathrin-coated vesicles and retained
in late endosomes/lysosomes with no detectable nuclear
localization. In the presence of adenovirus, the Rep proteins
could translocate into the nucleus where they displayed a
biological activity.Results
Production and purification of recombinant Rep68 protein
To examine the ability of the TAT PTD to mediate the
intracellular internalization of AAV-2 Rep68 protein, pro-Fig. 1. Design and in vitro analysis of recombinant Rep proteins. (A) Representatio
Rep proteins. H: histidine tag. Black box corresponds to the TAT PTD (YGRKKR
staining with Coomassie blue. (C) Western blot analysis of purified R68 and TR
recombinant Rep proteins. The substrate of the assay was a plasmid with no ITR
generate two DNA fragments of the indicated size. After incubation with the reco
1.0% agarose gel that was dried and exposed to a film for autoradiography. Thekaryotic expression vectors encoding for TAT-Rep68 (TR68)
or a recombinant Rep68 devoid of any PTD (R68) were
constructed and used to produce recombinant proteins that
were purified using affinity columns (Fig. 1A). The analysis
of the eluted fractions indicated that Rep proteins of the
expected size were generated (Figs. 1B and C). Additionally,
recombinant h-Gal and TAT-h-Gal (T-h-Gal) proteins were
also produced and similarly purified (data not shown).
Because the addition of TAT could have altered or even
abolished its activity, the recombinant TR68 protein was
subsequently tested for its biological activity using an in
vitro replication assay (Nony et al., 2001; Ward and Berns,
1996). For this, linear double-stranded DNA molecules,
derived from the digestion of a plasmid containing or not the
AAV ITR, were incubated with the recombinant proteins
and cell extracts in the presence of labeled nucleotides. As
shown in Fig. 1D, addition of purified R68 resulted in a
significant incorporation of labeled nucleotides only in the
band containing the ITR as compared to what observed with
a control h-Gal protein or using a plasmid with no ITR
(pSP). A similar result was observed using the TR68
protein, indicating that both fusion proteins had retained
their biological activity.n of the Rep68 expression constructs used for the production of recombinant
RQRRR). (B) Analysis of purified Rep proteins by SDS/PAGE followed by
68 using an anti-Rep antibody (226.7). (D) In vitro replication activity of
(pSP) or with one ITR (pITR) that was predigested with XmnI and AflIII to
mbinant proteins, and the reaction mix, the DNA bands were resolved on a
arrow indicates the DNA fragment containing the AAV-2 ITR.
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We next analyzed the ability of the Rep fusion proteins
to penetrate into the cells upon their addition in the media.Fig. 2. Analysis of the internalization of the recombinant proteins by immunofluo
(0.5 AM), or T-h-Gal (0.5 AM) for 1 h at 37 8C and stained using an anti-Rep anti
the cells were similarly analyzed 24 h after transfection with a rep-expressing plas
Gal (0.5 AM), or transfected with the pCMVLacZ plasmid were analyzed by immu
antibody. Scale bar: 5 Am.For this, HeLa cells were incubated for 1 h with different
doses of purified Rep protein and then analyzed by
immunofluorescence using an anti-Rep antibody. A low
but detectable cellular uptake of TR68 could be observedrescence. (A) HeLa cells were incubated with either R68 (1.5 AM), TR68
body (226.7) and a secondary FITC-labeled antibody. As a positive control,
mid pCMVRep. (B) HeLa cells incubated with either h-Gal (1.5 AM), T-h-
nofluorescence using an anti-h-Gal antibody and a secondary FITC-labeled
Fig. 3. Internalization of recombinant Rep68 in the absence of the histidine
tag. (A) Western blot analysis of enterokinase-digested or undigested R68.
Purified proteins were separated by SDS/PAGE, transferred on a nitro-
cellulose membrane, and hybridized either to an anti-Rep (303.9) or an anti-
tag histidine antibody. (B) HeLa cells were incubated with either
enterokinase-digested R68 (0.5 AM) or undigested R68 (0.5 AM) for 1 h
at 37 8C and then analyzed as indicated in the legend of Fig. 2A. Scale bar:
8 Am.
Fig. 4. Effect of soluble heparin on the internalization of R68 and TR68. HeLa cel
in the presence or in the absence of 2 Ag/ml of soluble heparin and then stained u
Scale bar: 5 Am.
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not shown). At this optimal concentration, most of the
cells treated with the TR68 protein displayed a punctuate
Rep signal located in the cytoplasm (Fig. 2A). In contrast,
an exclusive nuclear localization pattern was observed after
transfection of a rep-expressing plasmid (Fig. 2A).
Similarly the recombinant TAT-h-Gal protein was also
found to be exclusively located in the cytoplasm upon
incubation with the cells (Fig. 2B). Uptake of TR68 was
detectable as soon as 15 min post addition to the cells and
peaked between 1 and 2 h (data not shown). Most
surprisingly, the same cytoplasmic signal was also
observed using R68 in the absence of TAT even though
a threefold higher amount of purified protein (1.5 AM) had
to be used in order to reach a signal similar to that
observed with TR68 (Fig. 2A). In contrast, internalization
of recombinant h-Gal was not observed in the absence of
TAT (Fig. 2B). Importantly, uptake of R68 was also
observed after cleavage of the N-terminus histidine tag
indicating that this result reflected an intrinsic property of
this viral protein (Fig. 3). Binding of TAT and TAT-fusionls were incubated with either R68 (1.5 AM), TR68 (0.5 AM) for 1 h at 37 8C
sing an anti-Rep antibody (226.7), and a secondary FITC-labeled antibody.
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heparan sulfate proteoglycans and to be inhibited by low
amounts of soluble heparin (Tyagi et al., 2001). We
similarly incubated HeLa cells with increasing amounts of
soluble heparin (2–50 Ag/ml) and either TR68 (0.5 AM) or
R68 (1.5 AM). After 1 h of incubation the analysis by
immunofluorescence indicated that the intracellular uptake
of R68 and TR68 was completely inhibited at a concen-
tration of heparin as low as 2 Ag/ml (Fig. 4). This latter
result suggested that, as expected for TR68, cellular uptake
of R68 likely involved ionic interactions with cell surface
heparan sulfate proteoglycans.
Finally, recent studies have highlighted the possibility of
artifactual uptake of such fusion proteins into the cells due to
the fixation procedure employed before immunolabeling
(Lundberg et al., 2003; Richard et al., 2003). In order to
exclude such possibility, 293 cells were incubated with either
R68 or TR68 and then extensively trypsinized to remove any
membrane bound protein before preparing cell extracts. The
analysis by Western blot using an anti-Rep antibody revealed
the presence of a Rep signal further indicating that the cells
had taken up the purified proteins (Fig. 5A). However, in this
case, a longer incubation period (12 h) and a higher amount of
Rep proteins (3 AM) were required to be able to detect the
proteins (data not shown). This latter result can be explained
by the lower sensitivity of theWestern blot assay as compared
to the analysis by immunofluorescence. Importantly, the
analysis conducted on cells incubated with T-h-Gal at 4 8C in
the presence of sodium azide, to inhibit its uptake (Caron et
al., 2004; Fittipaldi et al., 2003), confirmed that treatment
with trypsin was sufficient to remove all the proteins bound at
the cell surface (Fig. 5B). All together, these results indicated
that recombinant Rep proteins could be taken up by the cells
and accumulated in the cytoplasm. In addition, these data
indicated that internalization of Rep68 was not dependent
upon the presence of a PTD domain at its N-terminus.Fig. 5. (A) Analysis of the internalization of the recombinant Rep proteins by Wes
3 AM for 12 h or left untreated () and subsequently trypsinized before Western
activity. 293 cells were treated with 0.5% sodium azide at 4 8C during 30 min bef
sodium azide. The cells were then washed, treated or not with trypsin (T), and lysed
h-Gal; : untreated cells.Intracellular route followed by recombinant R68 and TR68
proteins
Recent studies have indicated that proteins fused to
positively charged PTDs such as TAT can enter the cells
through different endocytic pathways involving caveolar
uptake or by lipid-raft mediated macropinocytosis (Fitti-
paldi et al., 2003; Wadia et al., 2004). A recent report also
indicated that the entire TAT protein could enter T cells
through clathrin-dependent endocytosis (Vendeville et al.,
2004). To investigate this point, HeLa cells were incubated
either with R68 or TR68 in the presence of fluorescently
labeled transferrin and then analyzed by immunofluores-
cence using an anti-Rep antibody. After a 30-min incuba-
tion, most of the internalized Rep signal co-localized with
transferrin indicating that the recombinant proteins had been
taken up by clathrin-coated vesicles (Fig. 6A). The
cytoplasmic Rep signal was abolished upon treatment with
the non-ionic detergent Triton X-100, to solubilize endo-
somes (Fittipaldi et al., 2003), or at 4 8C in the presence of
sodium azide (Fig. 6A). In contrast, no co-localization was
observed between Rep and labeled cholera toxin B that is
mainly internalized by caveolar endocytosis (Fig. 6B).
Finally, since clathrin-coated vesicles are known to progress
into late endosomes that eventually fuse with the cell
lysosomes, we tested whether Rep proteins also co-localized
within these vesicles at later times. As shown in Fig. 6C, 4 h
post-addition to the cellular milieu, R68 and TR68 were
concentrated around the nucleus where they co-localized in
part with Lamp-1, a late endosome/lysosome marker.
Adenovirus infection promotes nuclear translocation of Rep
proteins
In all previous analyses, R68 and TR68 were never
found localized in the nucleus even after extensivetern blot. 293 cells were either incubated with the indicated Rep proteins at
blot analysis using an anti-Rep antibody (226.7). (B) Control for trypsin
ore the incubation with 3 AM of T-h-Gal for 1 h at 4 8C in the presence of
for Western blot analysis using an anti-histidine tag antibody. C: purified T-
Fig. 6. Intracellular localization of recombinant Rep proteins. (A) Left panels: HeLa cells were incubated with 20 Ag/ml of Alexa Fluor 568-conjugated
transferrin (Molecular Probes) and either R68 (1.5 AM) or TR68 (0.5 AM) for 30 min at 37 8C and then immunostained using an anti-Rep antibody (226.7).
Middle panels: the cells were treated with 0.5% sodium azide at 4 8C during 30 min before the addition of Rep and labeled transferrin. The cells were then
maintained at 4 8C for an additional 30 min in the presence of 0.5% sodium azide before immunostaining. Right panels: The cells were incubated with Rep and
transferrin for 30 min at 37 8C and then treated with ice-cold 1% triton X-100 in PBS for 20 min before immunostaining. (B) HeLa cells were incubated with
R68 (1.5 AM) and TR68 (0.5 AM) and 4 Ag/ml of Alexa Fluor 594-conjugated cholera toxin subunit B (Ctx B, Molecular Probes) for 30 min at 37 8C before
immunostaining. (C) HeLa cells were incubated with R68 and TR68 for 30 min at 37 8C and then stained with an anti-Rep (226.7) and an anti-Lamp-1
antibody and secondary FITC- and TRITC-labeled antibodies. Scale bars: 8 Am.
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tained a nuclear localization signal (nls) at the C-terminus
(Cassell and Weitzman, 2004). This observation, together
with the one showing co-localization of Rep with Lamp-1
(Fig. 6C), strongly suggested that the fusion proteins
were not able to escape from the endosomes following
their uptake into endocytic vesicles. Consequently, we
tested whether endosome disruption by addition of ade-
novirus (Seth, 1994) could promote the translocation of
Rep to the nucleus. HeLa cells were incubated with R68
and TR68 for 4 h and then infected with the DE1
replication-defective Ad-dl324 for two additional hours
to allow the virus to bind and enter the cell. In the
presence of adenovirus both R68 and TR68 could be
detected in the nucleus of the cells (Fig. 7). Interestingly,
a substantial amount of the proteins were still localized in
the cytoplasm where they formed large aggregates. A
prolonged incubation with the virus or the simultaneous
addition of Rep proteins did not alter this pattern (data
not shown) suggesting that the majority of the Rep
proteins were irreversibly trapped in the endosomal
compartment.Fig. 7. Adenovirus-induced nuclear translocation of recombinant Rep proteins. H
washed, and then infected with Ad-dl324 at an MOI of 5 for 2 h before immunoBiological activity of the endocytosed Rep proteins
Finally, we examined whether the delivered Rep pro-
teins were biologically active. Rep proteins, and partic-
ularly R68, are involved in AAV DNA replication and
regulation of their own expression (Beaton et al., 1989;
Brister and Muzyczka, 2000; Im and Muzyczka, 1990;
Pereira et al., 1997). Both of these activities take place in
the nucleus. Given our previous finding indicating that
the fusion Rep proteins were exclusively cytoplasmic
unless adenovirus was added, we first tested whether they
could induce AAV DNA replication when added to the
cells in the presence of adenovirus. For this, we used a
stable cell line derived from 293 cells that contains an
integrated recombinant AAV vector encoding for GFP
(AAVGFP). In this model, rescue and replication of the
rAAV vector can take place only in the presence of
adenovirus and Rep proteins. The 293-AAVGFP cells
were first incubated with R68 and TR68 and then
infected with adenovirus. AAV replication was analyzed
48 h later by Southern blot of genomic DNA using a
GFP probe. As expected, replication of the rAAV vectoreLa cells were incubated with R68 (1.5 AM) and TR68 (0.5 AM) for 4 h,
staining using an anti-Rep antibody (226.7). Scale bar: 8 Am.
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proteins were provided by transfection of a rep-express-
ing plasmid (Fig. 8, lane 4). Similarly, replicative forms
were also detected after incubation of the cells with R68,
and TR68 in the presence of adenovirus even though at a
lower level (Fig. 8, lanes 5–6). The minimal dose of R68
and TR68 sufficient to induce AAV replication was of
1.5 AM and 0.75 AM, respectively, and a maximal effect
was observed at 3 AM (data not shown). The absence of
adenovirus or the use of recombinant Rep proteins
mutated in their endonuclease domain (RY156F and
TRY156F) (Davis et al., 2000), prevented replication of
the vector DNA (Fig. 8, lanes 7–10). This result
indicated that the Rep proteins found in the nucleus of
the cell after adenovirus infection are biologically active.
To further substantiate this observation we also inves-
tigated whether these proteins were able to down-regulate
the activity of their own promoter. For this, 293 cells
were first incubated with the different recombinant
proteins and subsequently transfected with a chimeric
construct encoding for the GFP under the control of the
AAV p5 promoter (p5-GFP). To validate this assay cells
were also cotransfected with a rep-expressing plasmid in
the absence of any Rep fusion protein. As expected, in
this latter case, a decrease in the number of GFP
expressing cells was observed, confirming that Rep was
able to down-regulate this construct in the context of 293
cells (Fig. 9). Interestingly, both R68 and TR68 were
similarly able to inhibit the p5 promoter whereas a
control T-h-Gal protein proved ineffective. It is note-Fig. 8. Recombinant Rep proteins can induce rAAV replication. 293-
AAVGFP cells were either transfected with pCMVRep or incubated with
the indicated recombinant proteins (3 AM) for 5 h at 37 8C and then infected
with Ad-dl324 (Ad5) at an MOI of 5. Forty-eight hours later, DNA was
extracted and analyzed by Southern blot using a GFP probe. mRF:
monomer replicative form; dRF: dimer replicative form; ssDNA: single-
stranded DNA.worthy that in this experiment no adenovirus was added.
It is likely that in this context, the biological effect
observed is due to the translocation of the protein into
the nucleus after endosome disruption caused by the
calcium-phosphate transfection complex (see Discussion
section).Discussion
This study described for the first time that recombinant
Rep68 could be endocytosed by the cells and retain its
biological activity. This finding adds the Rep68 protein to
the list of viral and non-viral factors that were previously
described as having the property to translocate into cells
(Leifert and Whitton, 2003; Tre´hin and Merkle, 2004; Will
et al., 2002). We found that recombinant Rep68, as TAT-
fused Rep68, could enter the cells through endocytosis into
clathrin-coated vesicles but that, in the absence of any
endosome-disrupting agent, the proteins remained trapped
into late endosomes/lysosomes with no apparent nuclear
translocation. Addition of adenovirus induced the nuclear
translocation of the recombinant proteins that were then able
to exert a biological effect. Even if these findings generally
confirmed those reported by other groups concerning
translocatory proteins, some points deserve some specific
observations.
First, it should be noted that the dose of Rep
necessary to observe a maximal cellular uptake and
biological activity were high, varying from 0.5 to 3 AM
depending on the protein and on the assay used. The
same doses of protein had to be used when Rep68 was
fused with other PTDs such as that derived from the
kaposi fibroblast growth factor or using a stretch of 11
arginine residues (Futaki et al., 2001; Rojas et al., 1998)
(data not shown). Similarly, equivalent concentrations of
unmodified Cre recombinase were required to observe an
efficient cellular uptake and biological activity (Will et
al., 2002). As already noted by others, this level of
protein indicated that uptake did not involve penetration
through a saturable receptor and suggested that the
binding to the cell surface is non-specific (Leifert and
Whitton, 2003). Interestingly, the absorption R68 was
inhibited in the presence of an excess of heparin
suggesting that, as reported for TAT-fused proteins (Tyagi
et al., 2001) and confirmed in the case of TR68, binding of
Rep to the cell surface is mediated by ionic interaction
involving heparan sulfate residues. The domain of Rep
involved in this interaction remains to be defined. Concern-
ing this point, it is worth noting that, even if the net charge
of Rep68 is neutral, two stretches of basic residues are
present in the C-terminal portion of the protein between
amino acids 490 and 511. These residues, that are also
present within Rep78, were previously found to mediate the
nuclear targeting of these proteins (Cassell and Weitzman,
2004). It will be interesting to evaluate if this same region
Fig. 9. Repression of p5-dependent GFP expression by recombinant Rep proteins. 293 cells were incubated with the indicated proteins (3 AM) for 5 h at 37 8C
and subsequently washed and transfected with plasmid p5-GFP using the calcium-phosphate procedure. (A) GFP expression was quantified 24 h later by flow
cytometry and (B) visualized by fluorescence microscopy.
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Second, we observed that both the TAT-fused or unfused
Rep proteins were mainly internalized into clathrin-coated
vesicles. Other reports have indicated that TAT fusion
proteins entered the cells via caveolae or after lipid raft
macropinocytosis (Ferrari et al., 2003; Fittipaldi et al., 2003;
Wadia et al., 2004). It is likely that the cell type analyzed,
the nature of the cargo, and eventually the dose of protein
used, could influence the intracellular route followed by
these chimeric proteins. Third, we were unable to observe
any nuclear uptake of the R68 and TR68 despite the
presence of a nls at the C-terminus of Rep68 (Cassell and
Weitzman, 2004). This finding strongly indicated that most
if not all the proteins remained trapped in the cytoplasm.
Accordingly, we observed that after a longer incubation
period part of the Rep signal co-localized with late endo-
somal vesicles. Finally, as noted by others using different
endosome disrupting agents such as lysosomotropic com-pounds, light, or a domain of the influenza virus hemag-
glutinin protein (Caron et al., 2004; Matsushita et al., 2004;
Wadia et al., 2004), infection with adenovirus allowed the
escape of some of the Rep proteins from their cytoplasmic
storage site and allowed their translocation to the nucleus.
Interestingly a previous report indicated that Rep proteins
could be lipofected into cells (Lamartina et al., 1998). It is
likely that in that case, lipofection also helped for the release
of Rep protein from endosomes.
In conclusion, this study evaluated the feasibility of an
alternative way to deliver biologically active Rep proteins to
cells. From a more fundamental point of view, the ability of
Rep68 to enter the cells becomes particularly relevant
considering that AAV can co-infect cells together with
adenovirus. Adenovirus infection could be important not
only to allow the escape of Rep from endosomes but also to
induce the release of the newly synthetized Rep proteins from
the infected cells as a consequence of its cytopathic effect.
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relevance of this observation.Materials and methods
Plasmids
To construct the plasmids encoding for R68 and
TR68, the rep68 cDNA was cloned into the BamHI site
of the pET-19b expression vector (Novagen) generating
the intermediate pRep68I construct. Nucleotides 321–839
of wt AAV-2 were then amplified by PCR using plasmid
pspRC (Salvetti et al., 1998) as a template and the fol-
lowing primers: 5V-GGAATTCCATATGCCGGGGTTTT-
ACGAGATTGT-3V/5V-TTCCATATTAGTCCACGCCC-3V
for the R68 construct, 5V-GGAATTCCATATGGGCTACG-
GCCGCAAGAAACGCCGCCAGCGCCGCCGCGGT-
GGACCGGGGTTTTACGAGATTGT-3V/5V-TTCCATAT-
TAGTCCACGCCC-3V, for the TR68 construct. The
amplified PCR fragments were digested with NdeI and
SacII and cloned into the unique NdeI and SacII sites of the
pRep68I, to generate plasmids pR68 and pTR68, respec-
tively. The pTAT-h-Gal and p-h-Gal plasmids were kindly
provided by S. F. Dowdy (Howard Hughes Medical Ins-
titute, La Jolla, USA). The pSP plasmid were generated by
replacing the BglII–HpaI fragment of the pSP72 (Promega)
with PmeI linker (New England Biolabs). The pITR plasmid
was obtained by cloning the PvuII–SnaBI AAV-2 ITR
fragment from pSub201 (Samulski et al., 1989) into the
HincII site of pSP. To obtain plasmid p5GFP the AAV-2 p5
promoter (nt 154 to 323 of wild type AAV-2) was amplified
by PCR using plasmid pAV2 as a template (Laughlin et al.,
1983) and the following primers: 5V-GGAGTCGTGACGT-
GAATTACG-3V/5V-ACCCCGCCATGGCGGCTG-3V). The
amplified PCR product that contained an NcoI site at Rep78
start codon was digested with HincII and NcoI and inserted
in plasmid pSP-BGHpA that contained the bovine growth
hormone (BGH) polyadenylation signal (pA), to create the
p5BGH construct. Finally, the eGFP cDNA was excised
with NcoI and XbaI from plasmid pEGFP-N1 (Clontech)
and then inserted between the same sites in plasmid p5BGH
to generate the p5GFP construct.
Cell culture and transfection procedure
293 and HeLa cells were propagated in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS) plus antibiotics at 37 8C
in 5% CO2. The 293-AAVGFP cell line was obtained by
transfecting 293 cells with plasmid encoding the rAAV-2-
GFP vector. Clones were isolated and selected by PCR for
the presence of the GFP gene then tested for rAAV replicat-
ion using an in vivo replication assay (Nony et al., 2001).
Transfections were performed using the calcium phosphate
procedure.Expression and purification of recombinant Rep proteins
The pR68, pTR68, pTAT-h-Gal, and p-h-Gal were
transformed into BL21 (DE3) pLysS cells (Invitrogen).
Transformed colonies were amplified in LB medium
(Sigma-Aldrich) containing 100 Ag/ml ampicillin and 34
Ag/ml chloramphenicol at 37 8C. Protein expression was
induced by addition of 0.5 mM isopropyl-h-D-thioglucoside
for 5 h at 37 8C during the growth phase. Cells were then
pelleted and resuspended in lysis buffer (50 mM NaH2PO4,
300 mM NaCl, 20 mM imidazole, pH 8.0) containing
lysozyme (1 mg/ml) and a protease inhibitors cocktail
(Roche), and incubated 30 min on ice before sonication.
Cell debris was removed by centrifugation and the cleared
supernatant was added to Ni-NTA column (Qiagen), pre-
washed with the lysis buffer. The column was washed
sequentially with the lysis buffer, then with the wash buffer
(50 mM NaH2PO4, 300 mM NaCl, and 50 mM Imidazole,
pH 8.0). The proteins were eluted with 6  0.5 ml of elution
buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM
imidazole, pH 8.0). The protein-containing fractions were
pooled, flash frozen in 10% glycerol and stored at 80 8C.
Protein concentrations were quantified using a Bradford
assay (BioRad).
Cleavage of R68 with enterokinase
Purified R68 was cleaved with recombinant enterokinase
(rEK; Novagen) (0.4 U/ Ag of Rep68) in rEK cleavage
buffer (20 mM Tris–HCl, 50 mM NaCl, and 2 mM CaCl2,
pH 7.4) for 22 h at 21 8C. EKapture agarose was then added
to remove enterokinase and the digestion product recovered
by spin-filtration. The digested R68 protein was finally
separated from the His-tag by spin-filtration on a Ni-NTA
agarose column.
Primary antibodies
The anti-Rep 303.9 and 226.7 mouse monoclonal anti-
bodies (kindly provided by J. Kleinschmidt, German Cancer
Center, Heidelberg, Germany) recognized the four Rep
proteins (Wistuba et al., 1995, 1997). They were used
undiluted for immunofluorescence or at a 1:20 dilution for
Western blot analysis. The anti-h-Gal antibodies were
purchased from Boehringer Manheim and used at a 1:100
dilution for immunofluorescence studies. The anti-Lamp-1
antibody (Santa Cruz Biotechnology) was used at a 1:40
dilution. The anti-histidine tag (Cell Signaling Technology)
and the anti-tubulin (Sigma) antibodies were used at a
1:2000 and 1:4000 dilution, respectively.
Western blot analysis
Cell extracts were prepared as described previously
(Geoffroy et al., 2004). Proteins were loaded on 7.5%
SDS–polyacrylamide gels and then transferred to nitro-
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recommendations (BioRad). The membranes were
blocked overnight at 4 8C, in PBS/0.1% Tween/5% dried
milk, and then incubated for 2 h at room temperature
(RT) with the appropriate antibody diluted in PBS/0.1%
Tween/5% dried milk. Anti-mouse HRP-conjugated sec-
ondary antibodies (Dako) were used at a 1:2000 dilution
in blocking buffer and incubated with the membrane for
1 h at RT. Blots were washed using PBS/0.1% Tween 20
(PBST). After washes in PBS/0.1% Tween, the mem-
branes were soaked in ECL reagent (enhanced chemilu-
minescence, Amersham Biosciences) and exposed to a
film.
Immunofluorescence
After incubation with the proteins in serum-free media,
the cells were washed with PBS, fixed with PBS/2%
paraformaldehyde, and permeabilized with PBS/0.2%
Triton X-100. Cells were then incubated with the primary
antibody for 1 h at RT, washed three times with PBST,
and then incubated with a secondary FITC-conjugated
antibody (Amersham Biosciences) used at 1:400 dilution
for 45 min at RT. To localize the nuclei, the cells were
stained for 30 min with TO-PRO-3 used at a 1:1000
dilution (T-3605, Molecular probe). After extensive
washes, the coverslips were mounted onto glass slides
using ProLong anti-fading mounting medium (Molecular
probe). Images were collected on a Leica TCS-SP1
confocal microscope with an X 63/1.4 oil immersion
lens. The green and red emissions were collected using
two photomultiplier tubes under conditions of no detect-
able channel overlap. The grayscale digital images were
visualized with a 24-bit imaging system including Leica’s
TCS-NT software. For colocalization experiments, R68
and TR68 recombinant proteins were incubated with 20
Ag/ml of Alexa Fluor 568-conjugated transferrin or 4 Ag/
ml of Alexa Fluor 594-conjugated cholera toxin subunit
B (Molecular Probes) for 30 min followed by immunos-
taining of the Rep proteins.
In vitro replication assay
DNA substrates were prepared by digestion of pSP
and pITR plasmids with XmnI and AflIII, followed by
phenol-chloroform extraction, ethanol precipitation, and
resuspension of the digested DNA in Tris-EDTA buffer.
Cell extracts were prepared and replication assays were
performed as described previously using 75 Ag of Ad-
infected cell extracts and 300 ng of recombinant proteins
(Ward et al., 1998).
In vivo replication assay
293-AAVGFP cells seeded into a 6-well plate were either
transfected with plasmid pCMV-rep, or treated for 5 h with3 AM of recombinant proteins in a serum-free media. The
cells were then washed and infected with Ad-dl324 (E1-
deleted Ad5) at a multiplicity of infection (MOI) of 5 or
mock infected. After 48 h post-infection, total DNA was
extracted and analyzed by Southern blot as previously
described (Nony et al., 2001).Acknowledgments
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